ArticleJournal of experimental & clinical cancer research : CR2026
Superior anti-DLBCL efficacy of novel organic arsenical Z2-A-Z2 through ROS-mediated apoptosis and critical NF-κB/IκBα signaling pathway inhibition.
Wenjiao Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.